Biotinidase deficiency represents an autosomal recessive inborn error of biotin metabolism causing late onset, biotin responsive, multiple carboxylase deficiency. [1] [2] [3] Biotinidase acts by recycling biotin through liberation from biocytin (F-aminobiotinyl lysine) or from short biotinyl peptides formed during proteolytic degradation of the biotin dependent carboxylases: propionyl-CoA carboxylase (PCC; EC 6.4.1.3), 3-methylcrotonyl-CoA carboxylase (MCC; EC 6.4.1.4), pyruvate carboxylase (PC; EC 6.4.1.1), and acetyl-CoA carboxylase (ACC; EC 6.4.1.2.). In biotinidase deficiency biocytin is lost in urine4 leading to progressive biotin depletion and subsequently to multiple carboxylase deficiency. 3 Biotinidase deficiency in its classical form usually presents during the first year of life with variable neurological signs (hypotonia, seizures, ataxia), dermatitis, alopecia, and recurrent infections. Metabolic acidosis and organic aciduria due to decreased activities of the biotin dependent carboxylases are inconsistently found. Despite rapid clinical and biochemical improvement after treatment with pharmacological doses of biotin, neurological damage such as sensorineural hearing loss, optic atrophy, ataxia, and mental retardation has been reported to persist. 3 5 6 Since the introduction of neonatal screening a number of children with partial biotinidase deficiency have been detected of whom most have remained clinically asymptomatic. 7 8 In the present paper a new variant of biotinidase deficiency with delayed onset of symptomatology is described. In addition the effect of biotin treatment will be presented.
Case report
The patient was the single child of healthy nonconsanguineous parents born in Poland after an uneventful pregnancy and delivery; his birth weight was 3250 g. Neurodevelopmental progress and growth in the first decade were reported to have been completely normal. At the age of 10 years the patient complained of acute visual loss during the course of a 'flu'-like illness. Bilateral optic atrophy was found and visual acuity was decreased to 20/100 with small bilateral coecocentral scotomata (see fig 1, upper 250 .tmol/l, that is, 27 times the concentration in plasma. Plasma and cerebrospinal fluid lactate and pyruvate were all within the normal range. Tiglylglycine, methylcitrate, and 3-methyl-crotonylglycine were not detected in any of the body fluids investigated. Prompt response to biotin supplementation was shown after 24 hours by normalisation of 3-OH-isovalerate concentrations in plasma (1 ,umol/l) and urine (9-7 iimollmmol creatinine). After four weeks a repeated lumbar puncture showed return of the 3-OH-isovalerate treatment was slightly raised, but was only 10% compared with the mean of biocytin excretion determined in 11 patients with complete biotinidase deficiency (mean (SD): 24-9 (8-3) nmol/mmol creatinine, range: 10-6-36-6). Biotinidase activity in the plasma of the patient measured by the colorimetric method was decreased to 4-4% of mean normal (table 1) . Surprisingly, biotinidase activities in plasma of the parents were within the normal range (table  1) .
The Eadie-Hofstee plots obtained from the kinetic analysis of biotinidase are shown in fig 2  and 
